Myovant Sciences Stock Total Asset
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
Myovant Sciences fundamentals help investors to digest information that contributes to Myovant Sciences' financial success or failures. It also enables traders to predict the movement of Myovant Stock. The fundamental analysis module provides a way to measure Myovant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myovant Sciences stock.
Myovant |
Myovant Sciences Company Total Asset Analysis
Myovant Sciences' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Myovant Sciences Total Asset | 520.01 M |
Most of Myovant Sciences' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myovant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Myovant Sciences has a Total Asset of 520.01 M. This is 93.08% lower than that of the Biotechnology sector and 73.68% lower than that of the Health Care industry. The total asset for all United States stocks is 98.24% higher than that of the company.
Myovant Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myovant Sciences' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics of similar companies.Myovant Sciences is currently under evaluation in total asset category among related companies.
Myovant Fundamentals
| Return On Asset | -0.18 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 2.6 B | |||
| Shares Outstanding | 97.26 M | |||
| Shares Owned By Insiders | 48.61 % | |||
| Shares Owned By Institutions | 56.21 % | |||
| Number Of Shares Shorted | 8.39 M | |||
| Price To Earning | (8.56) X | |||
| Price To Book | 70.01 X | |||
| Price To Sales | 7.80 X | |||
| Revenue | 230.97 M | |||
| Gross Profit | 72.02 M | |||
| EBITDA | (183.89 M) | |||
| Net Income | (205.98 M) | |||
| Cash And Equivalents | 371.29 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 358.7 M | |||
| Debt To Equity | 138.60 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (5.75) X | |||
| Cash Flow From Operations | (268.56 M) | |||
| Short Ratio | 11.21 X | |||
| Earnings Per Share | (1.92) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 579 | |||
| Beta | 2.15 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 520.01 M | |||
| Retained Earnings | (811.83 M) | |||
| Working Capital | 123.03 M | |||
| Current Asset | 150.17 M | |||
| Current Liabilities | 27.14 M | |||
| Z Score | 2.8 | |||
| Net Asset | 520.01 M |
About Myovant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myovant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |